ArticleBiomolecules2025
PRMT5 Identified as a Viable Target for Combination Therapy in Preclinical Models of Pancreatic Cancer.
Xiaolong Wei et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
ArticleBiomolecules2025
Xiaolong Wei et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.